Standex International Earnings Call Transcripts
Fiscal Year 2026
-
Sales grew 8.1% year-over-year with strong momentum in Electronics and Aerospace & Defense, driven by fast-growing end markets and new products. Federal Industries divestiture enabled debt reduction and portfolio focus, while guidance calls for continued revenue and margin expansion.
-
Q2 FY26 saw 16.6% revenue growth, led by Electronics and strong new product sales, with record orders and improved margins. Capacity expansions and investments support continued growth, especially in grid and fast growth markets, while guidance for FY26 is reiterated.
-
Q1 2026 saw revenue up 27.6% year-over-year, driven by acquisitions, new products, and fast-growth markets. The sales outlook for FY26 was raised, with strong order momentum and robust performance from the rebranded Grid business. Margin expansion and ongoing debt reduction support future growth.
Fiscal Year 2025
-
Q4 2025 saw 23% revenue growth, record margins, and strong cash flow, driven by acquisitions and fast growth markets. FY26 guidance calls for $100M+ revenue growth, margin expansion, and over 15 new product launches, with continued focus on debt reduction and operational execution.
-
Record Q3 results with 17.2% revenue growth driven by acquisitions, strong margins, and fast-growth end markets. Outlook remains positive with new product launches, ongoing integration of recent acquisitions, and a focus on deleveraging and organic growth in FY2026.
-
Record adjusted operating margin and strong acquisition-driven growth offset organic declines in key segments. Fast-growth market sales now exceed 20% of total, with new products and Amran/Narayan integration fueling optimism for higher revenue and margins in 2025.
-
Record gross and operating margins achieved despite a 7.7% revenue decline, with new product sales up 20% year-on-year. The $462M Amran-Narayan acquisition doubles exposure to fast-growth markets and is expected to be immediately accretive to all key metrics.
Fiscal Year 2024
-
Record profit and cash flow were achieved in fiscal 2024 despite a 4.3% Q4 sales decline, with margin expansion and robust R&D investment. Over 12 new products are set for release in fiscal 2025, supporting growth targets and margin improvement as market conditions stabilize.